In a webinar hosted by AC Immune, scientists discussed the various advantages of vaccines ranging from their expected safety and long-lasting immune responses to potentially lower costs in treating and possibly preventingParkinsonsand Alzheimers disease.
The Key Opinion Leader webinar, broadcasted on Aug. 24 and available for viewing, offered a presentation by Cynthia A. Lemere, PhD, a scientist at the Ann Romney Center for Neurologic Diseases at Brigham & Womens Hospital and an associate professor of neurology at the Harvard Medical School. Lemere also works as a scientific advisor and consultant for AC Immune, among other companies.
Vaccines are a form of active immunotherapy for neurodegenerative diseases, which work bystimulating the immune system to produce antibodies against the abnormal, or misfolded, proteins driving these diseases. In the case of Parkinsons, clumps of the misfolded alpha-synuclein proteinspread throughout the brain and contribute to nerve cell death and disease progression.
AC Immune is planning to open a Phase 2 clinical trial of ACI-7104, a potential vaccine against the toxic alpha-synuclein protein in Parkinsons patients this year.
A newer generation of vaccines, called multi-epitope vaccines, target several epitopes the part of a protein that elicits an immune response on misfolded proteins. As such, they are designed to elicit a more powerful immune response, AC Immune reported in an accompanying company press release. Multi-epitope vaccines also contain adjuvants, additional components that boost immune responses.
Vaccines are designed to provide long-lasting immune activation, the speakers stated, leading to a consistent and gradual production of antibodies against misfolded protein clumps. This allows for greater safety and long-term efficacy than is possible with synthetic or lab-made monoclonal antibodies that only target one epitope. Monoclonal antibody treatment, the scientists explained, is a passive immunotherapy, with a relatively short-lived peak in antibody production compared with vaccines.
Its really a question of balancing efficacy and safety, Lemere said, speaking of monoclonal antibodies in studies for Alzheimers disease relative to potential vaccines.
Vaccines also enhance a persons own immune response.Active vaccination is a way to have the body basically make antibodies,Lemere said.
Vaccines can be administered as a simple injection, she added, while monoclonal antibodies are often infused over four hours during regularly scheduled hospital or clinic visits. They also can be cost-saving and less of a burden to patients, needing to be given possibly only once or twice a year, she added.
Contrary to monoclonal antibodies, however,the immune response triggered by vaccines cannot be shut down.
The ability of vaccines to safely and specifically target multiple epitopes on the toxic drivers of neurodegenerative disease makes them uniquely suited to address the unmet needs of patients, Lemere said in the release. Data from prior clinical studies conducted by AC Immune and others clearly highlight the therapeutic potential of vaccines and provide a strong scientific rationale for the Companys ongoing and planned trials.
Marie Kosco-Vilbois, PhD, chief scientific officer at AC Immune, and Johannes Streffer, MD, the companys chief medical officer, also spoke at the event.Theypresented an overview of the companys goals and pipeline ofcandidate vaccines.
ACI-7104, its lead candidate for Parkinsons and other synucleinopathies, diseases characterized by the accumulation of misfolded alpha-synuclein aggregates, was initially developed by Affiris and later acquired by AC Immune. It is designed to trigger a specific immune response against toxic aggregates of alpha-synuclein.
A Phase 1 clinical trial (NCT01568099) and its extension studies, sponsored by Affiris, in 21 people with early-stage Parkinsons supported the vaccines safety and tolerability with repeat injections (six doses in total). Patients treated at the highest dose, 75 micrograms, also showed a 51% drop inlevels of alpha-synuclein aggregates in the cerebrospinal fluid that surrounds the brain and spinal cord, its researchers reported in 2020, supporting further clinical testing.
The planned Phase 2 trial of ACI-7104 will evaluate an improved version of the vaccine, Streffer said. It is to be an adaptive and biomarker-based study that will initially determine an optimally safe and effective dose and confirm the Phase 1 trials findings. Up to 150 additional Parkinsons patients will then be enrolled for treatment and assessment at the selected dose.
This study is in preparation, Streffer said. We are planning to include the first participants later this year.
AC Immune also has two candidate vaccines for Alzheimers disease, ACI-35.030 and ACI-24.060, in clinical testing.
We believe these programs, together with our cutting-edge diagnostic imaging agents, position AC Immune to lead the field towards the earlier diagnosis and prevention of neurodegenerative disease, said Andrea Pfeifer, CEO ofAC Immune.
Originally posted here:
Potential of Vaccines in Treating Parkinson's, Alzheimer's Detailed | AC Immune to Launch Trial of Vaccine in Early-stage Parkinson's - Parkinson's...
- Overview of the Immune System - The Merck Manuals - March 18th, 2024
- What are the organs of the immune system? - InformedHealth.org - NCBI ... - January 17th, 2024
- Mom who homeschools her children reveals she lets her one-year-old play in and EAT mud - but insists it is goo - Daily Mail - November 26th, 2023
- The limits of nutritional supplements: they dont cure or prevent ailments, nor are they harmless - EL PAS USA - November 26th, 2023
- Here's how your gut affects your mental health, immune function and even cardiovascular health - indulgexpress - November 18th, 2023
- From fear to freedom: Anchor Paul LaGrone shares his story of sudden hair loss & the disease that caused it - ABC Action News Tampa Bay - May 9th, 2023
- Strengthen Your Immune System With 4 Simple Strategies - May 1st, 2023
- Immunodeficiency Awareness Month: What Is The Science Behind These Diseases? Know Warning Signs - ABP Live - May 1st, 2023
- Nearly 90% of patients with rare skin cancer respond to therapy that prevents tumors from evading the immune - cleveland.com - April 23rd, 2023
- University of Cincinnati researchers helping develop 'vaccine' to fight aggressive cancer - WKRC TV Cincinnati - April 23rd, 2023
- Sana Biotechnology Highlights Preclinical Hypoimmune Data for its Allogeneic CAR T Platform and Advancements with its In Vivo Fusogen Platform with... - April 23rd, 2023
- Immune System: Parts & Common Problems - Cleveland Clinic - March 21st, 2023
- Disorders of the Immune System | Johns Hopkins Medicine - March 21st, 2023
- Sometimes 15 Minutes Are More Than Enough To Improve Immune System, Sleep Quality And Depression - Revyuh - March 13th, 2023
- People produce endocannabinoids similar to compounds found in marijuana that are critical to many bodily functions - The Conversation Indonesia - February 24th, 2023
- Spending more time with your kids, grandkidsand their germsmay lower risk of a severe outcome from Covid-19, recent studies show - CNBC - December 20th, 2022
- Published in Journal for Immunotherapy of Cancer: Using Single-Cell Analysis to Assess the Effects of an Anti-OX40 Monoclonal Antibody in Its... - November 17th, 2022
- Man who had COVID-19 for 400 days finally cured after getting treated with antibodies, study says - msnNOW - November 17th, 2022
- Social Distancing: The Impact on Your Health and Immune System - Healthline - October 7th, 2022
- Unraveling the Mysteries of the Immune System - Duke University School of Medicine - October 7th, 2022
- When Will ISR Immune System Regulation Holding AB (publ) (STO:ISR) Become Profitable? - Simply Wall St - October 7th, 2022
- VitaGaming Introduces Immune Support and Collagen to help Gamers boost immunity and fight stress - PR Web - October 7th, 2022
- Ohio reports third U.S. death of person with monkeypox who had underlying health conditions - CNBC - October 7th, 2022
- How a select few people have been cured of HIV - PBS - October 7th, 2022
- BeniCaros Wins Nutrition Industry Executive 2022 Immune Health Award - GlobeNewswire - October 7th, 2022
- Seasonal superfoods to give your immune system a boost this autumn - Yahoo Entertainment - October 7th, 2022
- Whats Going Around: Flu cases confirmed locally - ABC27 - October 7th, 2022
- Contributor: How to Fight the Cold and the Flu This Season - AJMC.com Managed Markets Network - October 7th, 2022
- Updated COVID-19 Bivalent Booster Released in Time for Fall and Winter Omicron Wave - Cornell University The Cornell Daily Sun - October 7th, 2022
- Oralair pill that retrains the immune system to reduce risk of thunderstorm asthma - 7NEWS - October 7th, 2022
- COVID immune reaction could affect brain mechanisms and induce neurological symptoms - Sky News - October 7th, 2022
- 7 Surprising Health Benefits of Pumpkins - AARP - October 7th, 2022
- Why Do Some Allergies Go Away While Others Dont? - The Atlantic - October 7th, 2022
- 15 foods to boost the immune system - Medical News Today - September 4th, 2022
- The powerful supplement that could enhance your immune response to bacteria and viruses - Express - September 4th, 2022
- New research: Cancer-fighting viruses can boost body's immune response - The Indian Express - September 4th, 2022
- Long COVID: How researchers are zeroing in on the self-targeted immune attacks that may lurk behind it - The Conversation Indonesia - September 4th, 2022
- Study raises concerns about the effectiveness of the monkeypox vaccine - STAT - September 4th, 2022
- Five Natural Immune-Boosting Treatments to Try This Flu Season - Boston magazine - September 4th, 2022
- Returning to Football After COVID-19 Infection - Louisiana State University - September 4th, 2022
- #1 Best Way to Boost Your Immunity Against BA.5 Eat This Not That - Eat This, Not That - September 4th, 2022
- Whatever happened to the Botswana scientist who identified omicron then caught it? - NPR - September 4th, 2022
- Non-Hodgkin's lymphoma: What is the cancer that Jane Fonda announced she has? - FOX 29 Philadelphia - September 4th, 2022
- 8 Health Benefits of Cabbage - Health Essentials - September 4th, 2022
- Identification of cervical squamous cell carcinoma feature genes and construction of a prognostic model based on immune-related features - BMC Women's... - September 4th, 2022
- VICTOR DAVIS HANSON: The mysteries of Long COVID - Las Vegas Review-Journal - September 4th, 2022
- Is This Popular Montana City The Most Depressed In The Nation? - XL Country - September 4th, 2022
- First adapted COVID-19 booster vaccines recommended for approval in the EU | European Medicines Agency - European Medicines Agency | - September 4th, 2022
- What Are Zombie Cells? Here's How They Impact Aging - Prevention Magazine - September 4th, 2022
- What To Know About Hand, Foot and Mouth Disease - Health Essentials - September 4th, 2022
- On maternity and the stronger immune response in women - Nature.com - August 19th, 2022
- New study could change what we eat to supercharge immune system and fight disease - WOODTV.com - August 19th, 2022
- Extending dogs' lives, and sex and the immune system - MIT Technology Review - August 19th, 2022
- Your Immune System Will Thrive With This Elderberry Hill Liquid Morning Multivitamin - Men's Journal - August 19th, 2022
- Sure Signs Your Immune System Isn't as Strong as it Should Be Eat This Not That - Eat This, Not That - August 19th, 2022
- Can the monkeypox vaccine stop the current outbreak? : Goats and Soda - NPR - August 19th, 2022
- Getting A Grip On Influenza: The Pursuit Of A Universal Vaccine (Part 2) - Forbes - August 19th, 2022
- Bells Are Ringing! How Immunotherapy is Unlocking Doors to a Cancer Cure - Georgetowner - August 19th, 2022
- Have The Immune System Booster Through the Dietary Supplements Only from Berkeley Immune Support Formula - Digital Journal - August 19th, 2022
- COVID-19 and Flu Viruses Often Have a Deadly Accomplice: Bacterial Infections - Tufts Now - August 19th, 2022
- Eat This Fruit Daily to Stay Sharp and Live Longer, Research Find - The Beet - August 19th, 2022
- The Next COVID-19 Booster Shots Will Target Omicron: What to Know - Healthline - August 19th, 2022
- What to eat when you have COVID - Medical News Today - August 19th, 2022
- 3 Ways Good Inflammation Helps Your Body - First For Women - August 19th, 2022
- Bioinformatics analyses of potential ACLF biological mechanisms and identification of immune-related hub genes and vital miRNAs | Scientific Reports -... - August 19th, 2022
- Nasal vaccines could snuff out COVID, but the hurdles are not to be sneezed at - Sydney Morning Herald - August 19th, 2022
- Paxlovid Rebound: RWE Analysis and Alternative Therapies in Development - BioSpace - August 19th, 2022
- Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment - Nature.com - August 19th, 2022
- What Happens When Your Immune System Gets Stressed Out? - Cleveland Clinic - July 8th, 2022
- Alcohol and the Immune System - PMC - PubMed Central (PMC) - July 8th, 2022
- Small NIH study reveals how immune response triggered by COVID-19 may damage the brain - National Institutes of Health (.gov) - July 8th, 2022
- Hyperactivation of the immune system may cause post-COVID syndromes - EurekAlert - July 8th, 2022
- Stress accelerates aging of the immune system - Open Access Government - July 8th, 2022
- Fight off Stress With Immune-Boosting Nutrients the right way - Longevity LIVE - July 8th, 2022
- Toxic chemical that can disrupt reproductive and immune system found in drinking water across country: Report - Times Now - July 8th, 2022
- COVID-19 and Osteoarthritis: Potential Connection and Outlook - Healthline - July 8th, 2022
- What is Your Gut Telling You? - Shepherd Express - July 8th, 2022
- How three kids got kidney transplants without immunosuppressants - Freethink - July 8th, 2022
- Coronavirus explainer: Can drinking green tea help with COVID symptoms? - Times of India - July 8th, 2022
- Immunization reduces the death rate in newborns - Times of India - July 8th, 2022